Innovation for Health - 13 February 2020
Contact
LinkedIn
Twitter
Facebook
Innovation for Health - Shaping the future of healthcare
Innovation for Health - Shaping the future of healthcare
Innovation for Health - Shaping the future of healthcare
Innovation for Health - Shaping the future of healthcare
Innovation for Health - Shaping the future of healthcare

Bert Leufkens

Principal Investigator, Utrecht University

Session

14:35 - 15:35
Impact of innovation for regulatory sciences

Bert is professor of Pharmaceutical Policy and Regulatory Science at Utrecht University. He is research and policy-wise active at several (inter)national platforms on innovation, drug safety, pharmaceutical policy and regulatory science (e.g. past-member EMA Pharmaco¬vigilance Working Party 2005-2009, chair of Dutch Medicines Evaluation Board (MEB) 2007-2017, past-member of the EMA CHMP 2009-2015, past-Pre¬si¬dent of ISPE, since 2008 Scientific Director of the Utrecht WHO Collaborating Centre for Pharmaceutical Policy and Regulation. He is affiliate professor at the Faculdade de Farmácia da Universidade de Lisboa and the Copenhagen Centre for Regulatory Science (CORS). Bert is member of the Scientific Leadership Team of Lygature since 2018. He is (co) author of >500 papers in peer reviewed journals, book chapters and research reports.

Abstract

Regulatory Innovation: opportunities for informed impact
An important driver of societal debate and concern is the misalignment between medical needs and innovation. In this context a pivotal question is whether regulatory systems are part of the problem or of the solution. In order to enable an informed, trusted and constructive rethink of the current regulatory system manner, evidence used to evaluate medicines and their impact on regulatory, clinical and societal outcomes is critical. This is the domain of regulatory science. Regulatory science is essential to improve regulatory effectiveness and efficiency and to enable timely access to new innovations. The days that medical innovation was framed as a big jump from the 'lab to practice' are in the past. The critical role of stakeholders including, among many others, patients, HTA bodies, payers and medical communities, is obvious. Regulatory innovation aims to shape opportunities for informed impact.

Mark van Houdenhoven
Sint Maartenskliniek
Mark van Houdenhoven
Troels Jordansen
Glycostem
Rob Kurver
KPN API store
Ton van der Steen
Erasmus MC Medical Delta

Marc Schellekens
LabHotel Rotterdam

Marc Schellekens
Ruben Kok
Dutch Techcentre for Life Sciences
Ruben Kok
Markwin Velders
Kite Pharma
Markwin Velders
Colja Laane
Mibiton
Colja Laane
Bert-Arjan Millenaar
NLC | The Healthtech Venture Builder
Bert-Arjan Millenaar
Annemiek Verkamman
HollandBIO
Claudia Wieringa
MSD
Joke Boonstra
Erasmus MC
Joke Boonstra
Ton de Boer
Medicines Evaluation Board
Anthonius de Boer
Onno van de Stolpe
Galapagos
Onno van de Stolpe

Kurt Gielen
Medace

Martijn Busstra
Erasmus MC
Ronald Stark
Netherlands strategic committee for Large-Scale Scientific Research Infrastructure
Ronald Stark
Joep de Groot
CbusineZ
Joep de Groot
Khatereh Ahmadi
MSD
Koos van der Hoeven
Radboud umc
Tom Miller
GreyBird Ventures
Tom Miller
Carine van den Brink
AXON Lawyers
Carine van den Brink
Eline Vrijland-van Beest
NightBalance
Eline Vrijland-van Beest
Edwin Moses
Ablynx
Edwin Moses
Maarten van Dongen
LabForRent
Maarten van Dongen

Eveline van Rijswijk
Science journalist & moderator

Jan de Kerpel
Kempen & Co
Jeff Gielen
Kadans Science Partner
Jeff Gielen

Arthur Lahr
Kiadis Pharma

Arthur Lahr
Paul Korte
Janssen

Will Ickenroth
Nemo Healthcare

Charlotte Kluit
MSD

Ton Rijnders
Lygature & Oncode Institute

André van de Sande
Interim Executive, Business Coach, Board Member

André van de Sande
Sangbreeta Moitra
Transform your Presence
Phil L'Huillier
MSD
Hans Schikan
Topsector LSH
Luc Sterkman
Caelus Health

Thomas Plochg
NPHF

Huib Kooijman
Ministry of Health

Peter Paul van Benthem
Dutch Association of Medical Specialists

Peter Paul van Benthem
Niels Chavannes
LUMC
Niels Chavannes

Zoraide Granchi
GenomeScan

Zoriade Granchi
Bert Leufkens
Utrecht University
Bert Leufkens

Maurits van Selms
ACTA

Maurits Selms
Chris van Hoof
imec
Chris van Hoof
Kees Recourt
Mibiton Foundation
Kees Recourt
Wiek van Gilst
UMCG
Wiek van Gilst
Marianne van der Steen
MERLN & RegMed XB
Marianne van der Steen
Stefan Braam
Ncardia
Stefan Braam
Werner Verbiest
Janssen Diagnostics
Werner Verbiest
Paul Vulto
Mimetas
Paul Vulto

Madelon Maurice
UMC Utrecht & Oncode Institute

Madelon Maurice
Rik Vos
Erasmus MC
Rik Vos
Eva van Rooijen
NLC | The Healthtech Venture Builder
Eva van Rooijen
Ingmar de Gooijer
myTomorrows
Ingmar de Gooijer
Eveliene Manten-Horst
AYA Jongvolwassen & Kanker
Eveliene Manten-Horst
Peter Hinssen
nexxworks
Peter Hinssen
Maaike Kleinsmann
TU Delft
Maaike Kleinsmann
Jos Malda
UMC Utrecht
Jos Malda
Nicolas Vergauwe
miDiagnostics
Nicolas Vergauwe

Henk van Houten
Royal Philips

Henk van Houten
Wietske Vrijland
Maasstad Ziekenhuis
Wietske Vrijland
Kurt Hertogs
Graphene.Works
Kurt Hertogs

Vladan Ilić
Westerdokters

Vladan Ilić

Koen Smits
Sioux
Sponsors & Partners 2019
Main partner
Health~Holland
Host sponsor
Erasmus MC
Host sponsor
Gemeente Rotterdam
Host sponsor
Life Sciences & Health 010
Platinum sponsor
MSD
Platinum sponsor
Janssen Diagnostics - Janssen
Gold sponsor
Medical Delta
Silver sponsor
NLC The Healthtec Venture Builder
Sponsor
Kempen
Award sponsor
AXON Lawyers
Award sponsor
Genmab
Partner
Vereniging Innovatieve Geneesmiddelen
Partner
Global Investor Forum
© 2019 Innovation for Health
Hyphen Projects uses cookies to remember certain preferences.